spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Vectra  

 HSMN NewsFeed - 25 May 2017
Medicare Coverage of Prolaris(R) Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate Cancer
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 18 Mar 2016
The Myriad myRisk(R) Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 8 Jan 2016
Counsyl Appoints Ted Snelgrove as Chief Business Officer
Diagnostics Personnel
 HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2015
Myriad Presents New myRisk(TM) Hereditary Cancer Data at 2015 ASCO Annual Meeting
Diagnostics Oncology
 HSMN NewsFeed - 8 Jan 2015
Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 2 Dec 2014
Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years
Diagnostics Urology Oncology
 HSMN NewsFeed - 19 Nov 2014
Crescendo Bioscience Highlights New Clinical Data on Vectra(R) DA at ACR
Diagnostics
 HSMN NewsFeed - 7 Nov 2014
Myriad myPath(TM) Melanoma Improves Diagnosis and Treatment Plans
Diagnostics Dermatology Oncology
 HSMN NewsFeed - 24 Oct 2014
Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe
Diagnostics Oncology
 HSMN NewsFeed - 9 Sep 2014
Myriad myPath(TM) Melanoma Test Reduced Indeterminate Cases by 76 Percent and Changed Treatment in 35 Percent of Cases
Diagnostics Oncology
 HSMN NewsFeed - 7 Apr 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Feb 2014
Questcor Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2013
Questcor Pharmaceuticals Acquires Rights to Synacthen(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 9 Dec 2009
Orthofix International Introduces New Line Of Walker Boots
Devices
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
Vectra
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!